Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home

Main sub menu

  • Investors
  • Careers
    • Working at Recipharm
    • The Recipharm story
    • Meet our employees
    • Current vacancies
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations
      • France
        • Fontaine
        • Kaysersberg
        • Monts
        • Pessac
      • Germany
        • Monheim
        • Wasserburg
        • Zwickau
      • India
        • Bengaluru
        • Karnal / Paonta Sahib
      • Israel
        • Ness Ziona
      • Italy
        • Brescia
        • Lainate
        • Masate
        • Paderno Dugnano
        • Pianezza
      • Portugal
        • Odivelas
        • Queluz
      • Spain
        • Parets
        • Leganés
      • Sweden
        • Höganäs
        • Stockholm city (HQ)
        • Karlskoga
        • Solna
        • Stockholm
        • Strängnäs
        • Uppsala
        • Uppsala Development
      • UK
        • Ashton
        • Cramlington
        • Holmes Chapel
        • Queenborough
      • USA
        • Research Triangle Park

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Analytical Solutions™
    • Recipharm Inhalation Solutions™
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Bespak
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Business overview
    • Sustainability
    • Company history

Press & events

What's happening?

Stay updated on our latest news and events.

Press and Event

  • Press
  • Events
  • Reports
  • Insights
Displaying 201 - 210 of 356

Subscribe

Press

Recipharm makes strategic investment in Synthonics and partners in development of novel compounds

2015.04.14 Read more

Press

Announcement from the nomination committee concerning the Annual General Meeting 2015

2015.04.08 Read more

Press

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF RECIPHARM AB (PUBL)

2015.04.08 Read more

Press

Recipharm and Adroit Science form collaboration to expand service offering

2015.03.26 Read more

Press

Recipharm completes Korean serialisation project for Abbott as the CDMO continues international roll out

2015.03.18 Read more

Press

Recipharm appoints new position of Vice President Quality Management

2015.03.10 Read more

Press

Change in the total number of shares and votes in Recipharm AB (publ)

2015.02.27 Read more

Press

Recipharm presents its seventh International Environmental Award winner

2015.02.26 Read more

Press

Full-Year-report January-December 2014

2015.02.19 Read more

Press

Invitation to presentation of Recipharm’s Full-Year-report for 2014 on 19 February 2015

2015.02.16 Read more

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Current page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • …
  • Next page Next ›
  • Last page Last »

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
  • T&C of sale and delivery
© 2020 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå